-- Capital One, CoreLogic, Google, Marathon, NCI, Sears: U.S. Equity Movers
-- B y   K a t i a   P o r z e c a n s k i
-- 2012-01-20T21:36:27Z
-- http://www.bloomberg.com/news/2012-01-19/capital-one-flextronics-google-ibm-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in  New York .  AsiaInfo-Linkage Inc. (ASIA)   surged 19 percent, the most
since Aug. 11, to $11.78. The Chinese telecommunications
software provider said it receiving a buyout proposal from Power
Joy (Cayman) Ltd., a state-owned private-equity fund, at a
premium to its stock price.  Capital One Financial Corp. (COF)   slumped 5.6 percent,
the most since Sept. 2, to $46.03. The credit-card issuer
seeking approval to purchase ING Groep NV’s U.S. online bank
said fourth-quarter profit fell 42 percent as expenses rose.  Cogent Communications Group Inc. (CCOI)   sank 19 percent,
the most since December 2008, to $15.30. The Internet-service
provider fell after file-sharing site Megaupload.com was shut
down by U.S. authorities as part of a copyright-infringement
investigation. Cogent is one of the companies that hosted
Megaupload.com, Wired.com reported.  CoreLogic Inc. (CLGX)   rallied 4.7 percent to $14.43, the
highest price since Aug. 3. The seller of property and credit
data forecast earnings in 2012 of at least 95 cents a share,
exceeding the average analyst estimate of 89 cents.  Google Inc. (GOOG)   fell 8.4 percent to $585.99, after
losing 8.4 percent for the biggest loss in the Standard & Poor’s
500 Index. The owner of the world’s most popular Internet search
engine reported fourth-quarter revenue and profit that missed
analysts’ estimates as an economic slowdown in  Europe  crimped
international sales.  Insmed Inc. (INSM)   surged 32 percent, the biggest gain
in the  Russell 2000  Index, to $5.01. The  Food and Drug
Administration  lifted a suspension of clinical trials of the
company’s experimental drug Arikace for patients with non-
tuberculous mycobacteria lung disease.  International Business Machines Corp. (IBM)   advanced 4.4
percent, the most since July 19, to $188.52. The world’s biggest
computer-services provider forecast 2012 earnings exceeding
analysts’ estimates after fourth-quarter profit rose 4.4 percent
because of rising software demand.  Intuitive Surgical Inc. (ISRG)   sank 6.1 percent, the
most since Aug. 8, to $445.68. The maker of a robotic system to
perform surgery said annual growth in its da Vinci surgical
procedures slowed to 27 percent in the fourth quarter from 30
percent in the third quarter.  JDS Uniphase Corp. (JDSU)   rose 4 percent to $13.45, the
highest price since Sept. 15. The maker of fiber-optic equipment
was raised to “buy” from “hold” at Stifel Nicolaus & Co.,
which said the company has a “sustainable competitive
advantage.”  Marathon Petroleum Corp. (MPC)  (MPC US) jumped 3.7 percent to
$37.17, the highest price since Nov. 11. The largest independent
U.S. refiner by market value outperformed competitors after
hedge fund Jana Partners LLC bought a 5.5 percent stake in the
company.  Microsoft Corp. (MSFT)   climbed 5.7 percent, the biggest
gain in the  Dow Jones Industrial Average , to $29.71. The world’s
largest software maker reported second-quarter profit that beat
estimates, lifted by holiday sales of Xbox machines and Kinect
sensors, as well as corporate software demand.  NCI Inc. (NCIT)   tumbled 32 percent, the biggest drop in
the Russell 2000, to $7.80. The designer of information
technology systems for government agencies forecast 2012 revenue
of no more than $360 million, missing the average analyst
estimate of $510.8 million.  Parker Hannifin Corp. (PH)   slumped 4.1 percent, the most
since Nov. 9, to $81.52. The maker of fluid power systems and
air-conditioning products lowered its earnings forecast for 2012
to no more than $7.30 a share from an earlier prediction of as
much as $7.85, citing international business conditions.  Sears Holdings Corp. (SHLD)   rose the most in the  S&P
500 , climbing 13 percent to $49. CIT Group Inc. (CIT US)
extended credit to the retailer even though letter of credit
hasn’t been given, New York Post reported late yesterday, citing
people close to the matter.  Skyworks Solutions Inc. (SWKS)   rose 11 percent to
$21.39, the highest price since Nov. 4. The maker of flash-
memory cards forecast second-quarter revenue of $360 million,
exceeding the average analyst estimate of $349.1 million.  Sonoco Products Co. (SON)   fell 5.3 percent, the most
since Aug. 8, to $31.93. The industrial and consumer packaging
manufacturer lowered its forecast of 2011 earnings excluding
some items to no more than $2.30 a share, below the average
analyst estimate of $2.43.  SunTrust Banks Inc. (STI)   rallied 5.2 percent to $21.29,
the highest price since Aug. 5.  Georgia ’s largest bank said
fourth-quarter earnings were 28 cents a share, beating the
average analyst estimate of 27 cents. The Atlanta-based
company’s sales missed the average estimate by 2.3 percent.  Talbots Inc. (TLD)  (TLB US) surged 19 percent to $3.19, the
highest price since Sept. 20. CNBC reported that Golden Gate
Capital Corp. and TPG Capital were considering bids for the
retailer. Talbots said in a statement that it doesn’t comment on
unusual market activity.  TreeHouse Foods Inc. (THS)   erased 9.7 percent, the most
since Aug. 5, to $56.76. The Westchester, Illinois-based food
company forecast earnings in 2011 of no more than $2.73 a share,
missing the average analyst estimate of $2.94, citing December
sales volumes.  U.S. Gold Corp. (UXG)   rose 7.6 percent to $4.98, the
highest price since Sept. 21. The mining company’s acquisition
of Minera Andes Inc. (MNEAF US) was approved by shareholders.  Voc Energy Trust (VOC)  (VOC US) fell 12 percent, the most since
it went public in May, to $21.55. The owner of oil and natural
gas properties reduced its quarterly dividend to 44 cents per
unit from 56 cents. Robert W. Baird & Co. cut its rating to
“underperform” from “outperform.”  Zoll Medical Corp. (ZOLL)   rose 5 percent, the most since
Dec. 15, to $67.64. The maker of defibrillators reported first-
quarter earnings of 29 cents a share, topping the 26-cent profit
predicted by analysts on average.  -- With assistance from  Lu Wang , Inyoung Hwang, and Whitney
Kisling in New York. Editor: Stephen Kleege  Katia Porzecanski in New York at +1-212-617-0408 or
 kporzecansk1@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 